Report cover image

Next-Generation Sequencing Market and Kalorama Survey of NGS Laboratories

Publisher Kalorama Information
Published Aug 02, 2019
Length 86 Pages
SKU # KLI16038423

Description

Next-Generation Sequencing Market and Kalorama Survey of NGS Laboratories

Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next-Generation Sequencing Market and Kalorama Survey of NGS Laboratories provides an in-depth look at the sequencing market, including data for 2018-2023 for the following markets:
  • NGS Sequencing Market, 2018-2023
  • Estimated Sequencing System Market Revenues, 2018-2023
  • Estimated Sequencing System Consumable Market Revenues, 2018-2023
  • Estimated Sequencing System Market Revenues, 2018-2023
  • Estimated Shares by Product Type, 2018 (%)
  • Forecast Shares by Product Type, 2023 (%)
  • Regional Breakout and Market Share by Vendor
This report includes a Survey of Labs Using Next-Generation Sequencing. The survey was conducted by an experienced NGS market analyst who interviewed lab managers and directors to obtain a real-world view point on the next-generation sequencing market today.
  • Please describe the lab’s industry and function?
  • How many sequencers does the laboratory have, and which models?
  • For your most recent sequencers, please describe: the model, what applications are run typically (by percentage), how often or how many samples (runs, samples, slides, flow cells, plates, multiplexed or not).
  • Which applications are expected to increase most?
  • Does the lab outsource any sequencing? For what reason(s)?
  • How does the lab/ organization address regulated patient samples?
  • Does the lab have accreditation for regulated patient samples?
  • Which sequencers are used for regulated and non-regulated patient samples?
  • In what disease areas does the lab sequence regulated/ non-regulated patient/ human samples? What disease areas are expected to grow the most from 2017-2018?
  • What percentage of samples sequenced are patient samples subject to regulation, patient/ human samples not subject to regulation, and non-patient/ non-human samples not subject to regulation? How is this expected to change from 2017-2018
  • How much is the volume of NGS and capillary sequencing expected to change overall from 2017 to 2018?
  • What sequencer features, or steps in the sequencing process would you most like to be changed/ improved?
  • What is the main bottleneck in your sequencing process (ie at what step do things back up)?
  • How challenging are data analysis and data management?
  • Which systems would the lab most likely consider for future purchases?
  • What is the likely time-frame for future sequencer purchases?
  • Which systems are likely to be used in the future for regulated patient samples (and are not being used currently for that)?
  • What barriers or other issues would hinder the growth of sequencing, particularly NGS, in clinical areas?
Company profiles – next-generation sequencing companies:
  • 10X Genomics
  • BGI Genomics (formerly Beijing Genome Institute)
  • Illumina
  • Oxford Nanopore
  • Promega Corporation
  • Qiagen N.V.
  • Roche Diagnostics
  • Swift Biosciences
  • Thermo Fisher Scientific Inc.

Table of Contents

86 Pages
    • Overall Sequencing Market Revenues
    • Scope
    • Methodology
    • Outline
    • Demographics
    • Overall Installed Base
    • Installed Base by Region
    • Installed Base by Industry Segment
    • Installed Base by Laboratory Function
    • Sequencer Applications and Usage
    • Clinical Applications
    • Key Criteria for Choosing Sequencers
    • Changes or Improvements
    • Bottlenecks in Process
    • Time-Frame of Purchase Plans
    • Systems Likely to Consider for Purchase
    • 10X Genomics
    • BGI Genomics (formerly Beijing Genome Institute)
    • Illumina
    • Oxford Nanopore
    • Promega Corporation
    • QIAGEN N.V.
    • Roche Diagnostics
    • Swift Biosciences
    • Thermo Fisher Scientific Inc.
    • Library Preparation Related Systems (% of Systems, Count)
    • Library Preparation Related Systems (% of Systems)
    • Library Preparation Related Systems (% of Labs Responding, Count)
    • Library Preparation Related Systems (% of Labs Responding)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us